Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Hemangioma, Cavernous, Central Nervous System
×
1 year
×
Clear all
Filters
3
NCT02603328
2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2
Completed
80 enrolled
19 charts
NCT05085561
2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2
Completed
62 enrolled